Your browser is no longer supported. Please, upgrade your browser.
PFE Pfizer Inc. daily Stock Chart
Pfizer Inc.
IndexDJIA S&P500 P/E26.37 EPS (ttm)1.37 Insider Own0.03% Shs Outstand5.96B Perf Week-0.55%
Market Cap215.63B Forward P/E13.13 EPS next Y2.76 Insider Trans-19.54% Shs Float5.92B Perf Month1.83%
Income8.35B PEG4.37 EPS next Q0.64 Inst Own71.30% Short Float0.83% Perf Quarter7.67%
Sales52.35B P/S4.12 EPS this Y5.20% Inst Trans-0.05% Short Ratio2.86 Perf Half Y7.71%
Book/sh9.79 P/B3.70 EPS next Y7.66% ROA4.90% Target Price38.15 Perf Year11.38%
Cash/sh2.41 P/C15.04 EPS next 5Y6.03% ROE14.00% 52W Range29.83 - 36.60 Perf YTD11.45%
Dividend1.28 P/FCF14.18 EPS past 5Y3.30% ROI7.80% 52W High-1.09% Beta1.00
Dividend %3.54% Quick Ratio1.10 Sales past 5Y-2.80% Gross Margin78.20% 52W Low21.35% ATR0.44
Employees96500 Current Ratio1.30 Sales Q/Q-1.90% Oper. Margin20.80% RSI (14)63.94 Volatility1.12% 1.09%
OptionableYes Debt/Eq0.75 EPS Q/Q52.90% Profit Margin16.00% Rel Volume0.82 Prev Close35.98
ShortableYes LT Debt/Eq0.59 EarningsOct 31 BMO Payout88.90% Avg Volume17.11M Price36.20
Recom2.50 SMA200.72% SMA504.47% SMA2007.76% Volume13,952,214 Change0.61%
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
May-04-16Reiterated UBS Buy $36 → $38
Apr-18-16Resumed Goldman Neutral $35
Apr-07-16Resumed Morgan Stanley Equal-Weight $35
Apr-07-16Resumed JP Morgan Overweight $38
Nov-25-15Upgrade Sun Trust Rbsn Humphrey Reduce → Neutral
Nov-03-15Reiterated Argus Buy $41 → $46
Oct-28-15Reiterated Deutsche Bank Buy $41 → $43
Oct-02-15Upgrade Morgan Stanley Equal-Weight → Overweight $35 → $38
Jul-29-15Reiterated Argus Buy $39 → $41
Jun-17-15Initiated Piper Jaffray Overweight
Apr-30-15Reiterated Argus Buy $36 → $39
Apr-29-15Downgrade Citigroup Buy → Neutral
Oct-17-17 05:59PM  Aerie (AERI) Up on FDA Review Committee Result for Rhopressa Zacks
05:00PM  This hot trade is about to get even hotter: Trader CNBC Videos
10:37AM  J&J (JNJ) Beats on Q3 Earnings, Actelion Buyout Drives Sales Zacks
09:44AM  Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen Zacks
08:09AM  The Blockbuster That Wasn't -- A CETP Inhibitor Post-Mortem Forbes
Oct-16-17 03:59PM  Pharma Industry Outlook - October 2017 Zacks
02:00PM  How Stock Investors Can Profit Big From Spinoffs Investopedia
10:58AM  The Cost Of Developing Drugs Is Insane. That Paper That Says Otherwise Is Insanely Bad Forbes
07:00AM  Pfizer Presents Full Results from Phase 2 Study of Next-Generation Investigational ALK-Inhibitor Lorlatinib in ALK-Positive and ROS1-Positive Advanced Non-Small Cell Lung Cancer Business Wire
06:49AM  [$$] Drugstore Favorites May Be Catching the Common Consumer Cold The Wall Street Journal
Oct-15-17 04:40PM  Pfizer Consumer Unit Worth as Much as $14 Billion
Oct-14-17 12:10AM  Earnings Season Preview: 2 Things to Watch For in Healthcare Motley Fool
12:05AM  Pfizer Says It's Pondering a Big Sale Motley Fool
Oct-13-17 04:14PM  5 Large-Cap Drug Stocks Well Poised to Beat on Q3 Earnings Zacks
12:20PM  Spin-Off ETF: Can the Outperformance Continue? Zacks
11:42AM  Behind Eli Lillys October Analyst Recommendations Market Realist
10:47AM  Pharma Sales Could Be Chilled by Hurricane Damage
09:32AM  Pfizer: Could a Big Merger Move the Needle?
08:06AM  Pharma Stock Roundup: Pfizer Mulls Options for Consumer Healthcare, LLY's Pipeline Setback Zacks
07:02AM  Gilead Sciences, Inc. (GILD) Stock Is Primed After Kite Pharma Buy InvestorPlace
01:35AM  2 Reasons Pfizer Is on Our Minds Today Motley Fool
Oct-12-17 11:04AM  [$$] Pfizer Seen Mulling Options
08:00AM  U.S. FDA Approves LYRICA® CR (pregabalin) Extended-Release Tablets CV Business Wire
07:20AM  Corporate News Blog - Pharma Giant Pfizer Mulling Divestment of Consumer Healthcare Business ACCESSWIRE
Oct-11-17 04:48PM  Is Pfizer the Best Dividend Stock in Healthcare? Motley Fool
03:05PM  Pfizer considers selling unit that includes Advil, ChapStick American City Business Journals
03:03PM  Three blue-chip US companies are on the verge of breaking apart, prodded by short-term investors Quartz
01:40PM  Pfizer: Who Will Pay $14B for Advil?
10:22AM  Pfizer Considering Sale/Spin-Off of Consumer Healthcare Unit Zacks
08:04AM  3 Reasons Why Pfizer Investors Will Win With a Consumer Business Sale or Spinoff Motley Fool
07:45AM  $100 Billion Question: Will Trump Let Alphabet, Pfizer Keep Tax Havens? Investor's Business Daily
03:02AM  [$$] The Reason Investors Love Spinoffs: Juicier Returns The Wall Street Journal
03:00AM  [$$] Pfizer Considers a Sale or Spinoff of Its Consumer Healthcare Business The Wall Street Journal
12:19AM  Asian shares higher after Wall Street sets new record high Associated Press
12:00AM  The Pharma Chief Who Sees Profit Where Skeptics See Lousy Odds Bloomberg
Oct-10-17 08:00PM  [$$] Spinoffs Juice Investor Returns The Wall Street Journal
05:18PM  Business Highlights Associated Press
05:11PM  Pfizer considers consumer business sale Associated Press
05:03PM  Dow Component Pfizer Mulls Over-The-Counter Spinoff Or Sale Investor's Business Daily
04:54PM  Wal-Mart and United climb while Procter & Gamble slumps Associated Press
02:07PM  Pfizer weighing sale of consumer health care business CNBC Videos
01:35PM  Pfizer Inc. -- Moody's: Sale of Pfizer consumer products would be positive for liquidity Moody's
01:30PM  Healthcare: Are These the Best Dividend Stocks to Buy Now? Motley Fool
01:07PM  Pfizer weighs $15 billion sale of consumer healthcare business Reuters
12:52PM  [$$] Pfizer: shelf medication Financial Times
12:43PM  [$$] Pfizer Reviews Options for Consumer Healthcare Business The Wall Street Journal
11:43AM  This Pfizer Disposal Won't Leave Investors Hanging Bloomberg
10:57AM  Going Long Pfizer Inc. (PFE) Stock Is an Easy Pill to Swallow InvestorPlace
10:36AM  Pfizer weighs $15 billion sale of consumer healthcare business Reuters
10:01AM  5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings Zacks
09:59AM  News Update Market Open CNBC Videos
09:45AM  Honeywell To Spin Off 2 Units; Pfizer Mulls Consumer Sale; P&G-Peltz Proxy Fight Today Investor's Business Daily
09:44AM  Stocks Climb; Wal-Mart Takes Buy Point, Tesla Gets Price Hike Investor's Business Daily
09:32AM  Pfizer weighs sale of consumer healthcare business Reuters
09:23AM  Stocks to Watch: AIG, Wal-Mart, Honeywell, Pfizer, P&G, United Continental, Microsoft The Wall Street Journal
09:00AM  Pfizer's Divestiture Plan No Big Deal Morningstar
08:30AM  [$$] Pfizer weighs sale of consumer health business Financial Times
08:15AM  Stocks making the biggest moves premarket: HON, PFE, WMT, AIG, MSFT & more CNBC
08:14AM  Pfizer Pops in Pre-Market After Group Considers Consumer Healthcare Sale
08:07AM  Pfizer Could Fall By 9% Or More Investopedia
07:51AM  Pfizer may sell consumer unit Associated Press
07:08AM  Pfizer to explore potential sale, spinoff of consumer healthcare business MarketWatch
06:58AM  Pfizer is exploring sale, spin-off of its consumer health-care business CNBC
06:45AM  Pfizer Reviewing Strategic Alternatives for Consumer Healthcare Business Business Wire
06:32AM  2 Big Safe Havens if the Stock Rally Crashes Investopedia
06:04AM  3 Healthcare Dividend Stocks Ideal for Retirees Motley Fool
Oct-09-17 10:35AM  Investors Are Scooping Up Shares of Apple, Ditching Bristol Myers and Pfizer
10:20AM  Forget Teva (TEVA), Buy These 5 Drug Stocks Instead Zacks
08:53AM  These 5 Dow Stocks Are Near Buy Zones As Earnings Season Begins Investor's Business Daily
07:44AM  Analysts Recommendations for Amgen in October 2017 Market Realist
07:22AM  This Dow stock looks poised to pull an Intel and break out to a multi-year high MarketWatch
Oct-07-17 10:43AM  3 Blockbuster Drugs That Still Cost More Than They Should Motley Fool
Oct-06-17 06:27PM  FDA: Drug shortages possible due to Puerto Rico power outage Associated Press
12:38PM  Missing Link: Long Capital One, Bristol-Myers CNBC Videos
Oct-05-17 04:37PM  4 Large-Cap Drug Stocks to Buy on Solid Momentum Ahead of Q3 Zacks
11:13AM  New Research: Key Drivers of Growth for Sprint, Pfizer, Oracle, Chesapeake Energy, Ford, and Verizon - A Look Behind the Scenes at Consolidated Results, Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
10:37AM  The 2 Surprising Reasons Exelixis, Inc. Lost 17% in September Motley Fool
08:00AM  Pfizer Launches Novel Programs to Put Important Support Services at the Fingertips of Cancer Patients Business Wire
Oct-04-17 07:30PM  3 High-Yield Billionaire Stocks Motley Fool
12:12PM  S.Africa watchdog drops over-charging probe into Aspen, Equity Reuters
10:10AM  S.Africa watchdog drops over-charging probe into Aspen, Equity Reuters
09:15AM  Allergan's Botox Gets FDA Nod for Forehead Line Treatment Zacks
08:12AM  The Zacks Analyst Blog Highlights: Pfizer, AT&T, BlackRock U.S. Bancorp and Walt Disney Zacks
Oct-03-17 05:43PM  Top Research Reports for Pfizer, AT&T & BlackRock Zacks
10:39AM  Is This How Drugmakers Will Kill Biosimilars? Motley Fool
10:19AM  [$$] Big Questions for Big Pharma
10:05AM  Gender Focus Proves Rewarding for This ETF Investopedia
08:36AM  3 Winning Dividend Strategies To Survive The Next Pullback Forbes
Oct-02-17 08:28PM  Markets Move Higher; Inversion Rules Put Pfizer-Allergan Back In Focus -- ICYMI
12:38PM  How To Trade The 8 'Dogs Of The Dow,' Which Outperformed The Dow In September Forbes
11:14AM  [$$] Lilly Faces Off With Pfizer, Novartis
09:00AM  Better Buy: Gilead Sciences, Inc. vs. Pfizer Motley Fool
Oct-01-17 07:03PM  Best Buy: Johnson & Johnson, Pfizer, or Gilead Sciences? Motley Fool
07:31AM  Pfizer Exposes the Sordid Underbelly of Drug Prices Motley Fool
Sep-29-17 10:40AM  Must-Know Changes to Bristol-Myers Squibbs Valuation Market Realist
09:08AM  Whats Johnson & Johnsons Valuation? Market Realist
08:28AM  Could Tax Reform Boost the Healthcare Sector? Market Realist
Sep-28-17 08:10PM  Is Pfizer Inc (PFE) A Buy At Its Current Price? Simply Wall St.
07:08PM  Cramer's lightning round: Re-pounding the table on DowDuP... CNBC Videos
06:51PM  Cramer's lightning round: Re-pounding the table on DowDuPont CNBC
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates through two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as dietary supplements, pain management, gastrointestinal, and respiratory and personal care. This segment offers products primarily under the Prevnar 13, Xeljanz, Eliquis, Lyrica, Enbrel, Viagra, Ibrance, Xtandi, Advil, and Centrum brands. The EH segment offers products that will lose or have lost marketing patent protection; branded generic products; sterile injectable products; biosimilars; and infusion systems. It provides products under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, and Pristiq brand names. This segment also engages in contract manufacturing business. The company has licensing agreements with Cellectis SA and AstraZeneca plc; and collaborative agreements with Eli Lilly & Company and Merck KGaA. It also has a research collaboration and license agreement with HitGen Ltd. to build and screen DNA-encoded libraries in order to discover small molecule leads to be used in drug development; collaboration with Merck and Corning for pharma glass packaging project; and an agreement with InSphero AG to develop a predictive toxicology assay using InSphero 3D InSight human liver microtissues for predicting drug induced liver injury. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PFIZER INC10% OwnerOct 10Buy17.0040,000680,0001,427,639Oct 10 04:22 PM
SUSMAN SALLYExecutive Vice PresidentSep 12Sale35.0038,2301,338,050115,096Sep 14 09:13 AM
MACKENZIE ALEXANDER RExecutive Vice PresidentSep 01Sale34.007,350249,900124,774Sep 05 06:15 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentAug 31Sale34.007,350249,900132,124Sep 01 06:37 PM
DAMELIO FRANK AExecutive Vice PresidentAug 31Sale34.0094,4093,209,906337,389Sep 01 06:37 PM
READ IAN CChairman & CEOAug 31Sale34.00141,1934,800,56280,762Sep 01 06:37 PM
READ IAN CChairman & CEOAug 31Sale34.0055,9751,903,150580,318Sep 01 06:37 PM
OLSON LAURIE JExecutive Vice PresidentAug 21Sale32.708,064263,69374,506Aug 23 03:51 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentAug 07Sale33.5015,000502,560139,474Aug 09 05:00 PM
READ IAN CChairman & CEOAug 04Sale34.0068,8342,340,356221,955Aug 08 05:02 PM
READ IAN CChairman & CEOAug 04Sale34.0028,116955,944636,293Aug 08 05:02 PM
JOHNSON RADY AExecutive Vice PresidentMar 10Sale34.194,500153,85554,963Mar 13 05:36 PM
HILL CHARLES HExecutive Vice PresidentMar 09Sale34.0736,0001,226,52057,329Mar 10 03:59 PM
LANKLER DOUGLAS MExecutive Vice PresidentMar 02Sale34.6620,000693,20083,793Mar 03 04:06 PM
Dolsten MikaelPresident R&DMar 02Sale34.5515,401532,10549,318Mar 03 04:06 PM
Dolsten MikaelPresident R&DMar 01Sale34.4815,569536,81964,719Mar 03 04:06 PM
Dolsten MikaelPresident R&DFeb 27Sale34.2658,8462,016,24480,288Mar 01 05:10 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23Option Exercise21.0321,238446,63572,172Feb 27 06:30 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 23Option Exercise21.03103,1552,169,350295,356Feb 27 06:30 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23Option Exercise21.0351,5781,084,685138,758Feb 27 06:30 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 23Option Exercise21.0321,238446,63533,848Feb 27 06:30 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 23Option Exercise21.03218,4474,593,940592,765Feb 27 06:21 PM
BOURLA ALBERTGroup PresidentFeb 23Option Exercise21.0342,476893,270165,474Feb 27 06:21 PM
Dolsten MikaelPresident R&DFeb 23Option Exercise21.03218,4474,593,940299,915Feb 27 06:21 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 23Option Exercise21.0336,408765,660102,611Feb 27 06:10 PM
READ IAN CChairman & CEOFeb 23Option Exercise21.03788,83516,589,2001,124,093Feb 27 06:55 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23Option Exercise21.03115,2912,424,570247,765Feb 27 06:55 PM
YOUNG JOHN DGroup PresidentFeb 23Option Exercise21.0351,5781,084,685172,542Feb 27 06:56 PM
OLSON LAURIE JExecutive Vice PresidentFeb 23Option Exercise21.0327,306574,24599,224Feb 27 06:47 PM
SMITH JAMES CDirectorDec 28Sale32.38247771,542Oct 16 05:26 PM
SMITH JAMES CDirectorDec 20Buy32.841,56651,4271,566Oct 16 05:26 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentDec 07Option Exercise25.8730,000776,100167,687Dec 08 09:48 PM
MADDALUNA ANTHONY JExecutive Vice PresidentNov 09Sale33.0010,000330,000112,087Nov 10 07:44 PM
BOURLA ALBERTGroup PresidentNov 04Option Exercise24.9920,000499,800149,199Nov 07 05:58 PM
BOURLA ALBERTGroup PresidentNov 04Sale30.0518,390552,530130,809Nov 07 05:58 PM
HILL CHARLES HExecutive Vice PresidentNov 03Option Exercise21.0353,9181,133,896115,033Nov 07 05:50 PM
MADDALUNA ANTHONY JExecutive Vice PresidentNov 02Option Exercise21.0332,545684,421122,087Nov 04 04:36 PM